Chatham, NJ (PRWEB) September 10, 2010
MMEG and Tobar LLC today announced a strategic partnership that will broaden and enhance MMEG’s expertise in specialized pharmaceutical marketing and commercial development.
“Through this partnership, our customers will benefit from the expanded depth of pharmaceutical marketing experience that our association with Tobar LLC brings to MMEG’s suite of services, especially in the vaccine, infectious disease, and niche markets where we have specialized since 2001,” says Joe Gillis, president and co-founder of MMEG.
In a statement, Peter Tobar, principal at Tobar, LLC, said, “MMEG is committed to developing engaging and scientifically relevant clinical communications. Together, MMEG and Tobar LLC will develop innovative initiatives to optimize the use of pharmaceutical brands. Additionally, MMEG offers an array of communications vehicles that deliver effective brand messaging to health care professionals.”
About MMEG: Formed in 2001, MMEG is MediMedia USA’s full-service clinical communications agency with core competencies in medical marketing, advisory services, and brand promotion. Over the last decade, MMEG has designed and delivered smart solutions that span the full brand life cycle. MMEG combines a creative approach to development, solid processes, and novel media channels to communicate compelling clinical messages for clients. http://www.mmeg.com
About Tobar LLC: Tobar LLC was established in January 2010 by Peter L. Tobar as a consulting company providing marketing support within the pharmaceutical and vaccines industry. Mr. Tobar, who serves as managing partner of Tobar LLC, has broad leadership experience in marketing and sales management, having worked 20 years for Wyeth Pharmacueticals. He is widely known in the industry for leading the marketing team that launched Prevnar, the most commercially successful vaccine worldwide.
26 Main Street, 3rd Floor
Chatham, NJ 07928
p. (973) 738-5700
f. (973) 738-5740
Text “MMEG” to 299669